April 16, 2014 7:05 AM ET

Biotechnology

Company Overview of Lumena Pharmaceuticals, Inc.

Executive Profile

Howard E. Greene

AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 1 different industries.

See Board Relationships
70--

Background

Mr. Howard E. Greene, also known as Ted Co-Founded Amylin Pharmaceuticals, Inc., in 1987 and also Co-Founded Biovest Partners. Mr. Greene served as Chief Executive Officer of Hybritech Incorporated, essentially from inception until its acquisition by Eli Lilly and Company in 1986. At Hybritech he was Co-Inventor of its principal product line, a monoclonal antibody assay system that has led to a new generation of immunodiagnostics, including the PSA screening test for ...

Corporate Headquarters

12531 High Bluff Drive
San Diego, California 92130

United States

Phone: 858-461-0694
Fax: --

Board Members Memberships

2011-Present
Director

Education

BA
Amherst College

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Lumena Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.